Posted on 9/28/18
KSQ Therapeutics Secures $80 Million
KSQ Therapeutics announced today that the company has secured an $80 million Series C financing to advance oncology drug candidates generated
Posted on 9/28/18
Working Mother Names Blue Cross Blue Shield Of Massachusetts As One Of The 2018 "100 Best Companies"
Blue Cross Blue Shield of Massachusetts (BCBSMA) has been named to the Working Mother 2018 "100 Best Companies" list, released today. The annual list celebrates companies . . .
Posted on 9/28/18
Aldeyra Therapeutics Announces Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced . . .
Posted on 9/27/18
Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics
Posted on 9/27/18
Here's Why T2 Biosystems Rose as Much as 16% Today
What happenedShares of T2 Biosystems (NASDAQ:TTOO) jumped as much as 16% today after the integrated clinical diagnostics company released performance data for its next potential growth . . .
Posted on 9/27/18
Aldeyra Therapeutics Announces Proposed Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced . . .
Posted on 9/26/18
Lyra Therapeutics Announces $29.5 Million Series B
Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases
Posted on 9/26/18
Alexion to Acquire Syntimmune for $1.2B
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune
Posted on 9/26/18
AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF)
Posted on 9/26/18
Entasis Therapeutics Announces Pricing of Initial Public Offering
WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Posted on 9/25/18
Morphic Therapeutic Announces $80 Million Financing
WALTHAM, Mass.--(BUSINESS WIRE)--Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that it has completed a $80 million Series B . . .
Posted on 9/25/18
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD)
Posted on 9/24/18
ZappRx Announces Partnership with Dunn Meadow Specialty Pharmacy
BOSTON--(BUSINESS WIRE)--ZappRx, adigital health company that streamlines the specialty medication prescribing process, announced today its partnership with Dunn Meadow, a national specialty pharmacy, headquartered in New . . .
Posted on 9/24/18
Cerveau Technologies Signs Research Agreement with Ionis Pharmaceuticals
BOSTON, Mass.--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration agreement with Ionis Pharmaceuticals, Inc. for use of [F-18]MK-6240, an investigational imaging agent to be used . . .
Posted on 9/23/18
Agenus Closes $15 Million Partial Royalty Monetization With XOMA
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies1, today announced the closing of its . . .
Posted on 9/23/18
Kala Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, today announced . . .
Posted on 9/20/18
Innovation Pharmaceuticals Provides Corporate Update
BEVERLY, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide a corporate update on . . .
Posted on 9/20/18
Merrimack Receives $5 Million Milestone Payment from Shire
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced that it has received a $5 million milestone payment from Shire, . . .
Posted on 9/20/18
Gentle Dental Partners is Now 42 North Dental
Gentle Dental Partners (Gentle Communications, LLC) has today announced a rebranding of the organization to 42 North Dental. The new name was created to better reflect . . .
Posted on 9/20/18
Thermo Fisher Scientific to Launch Global Customer Solution Centers
Thermo Fisher Scientific Inc., the world leader in serving science, today announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution . . .
Posted on 9/20/18
INQUE Is Named Runner-Up In The New England Business Association Innovation Awards
INQUE Holdings, LLC, a skin wellness technology and service company poised to disrupt the 10,000-year-old tattoo industry, has been named the runner-up in the "Rising Star" . . .
Posted on 9/20/18
Deciphera Pharmaceuticals: Will This ASCO Winner Repeat At ESMO?
SummaryThe share price has essentially doubled since last year's IPO.The valuation gap with larger competitor Blueprint Medicines appears enticing, even after the latter's recent decline.Initial data . . .
Posted on 9/19/18
Instrumentation Laboratory Awarded Massachusetts Life Sciences Center Tax Incentive
Instrumentation Laboratory (IL), today, announced their $525,000 tax incentive award from the Massachusetts Life Sciences Center (MLSC) as part of the Life Sciences Tax Incentive Program. . . .
Posted on 9/18/18
Gateway Health Extends Relationship with SS&C DST Health Solutions
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services software and software-enabled services, today announced that Gateway Health (Gateway) has extended its longstanding . . .
Posted on 9/18/18
Berkshire Hathaway Specialty Insurance Company Adds Key Product Line & Service Leaders in Dubai
BOSTON--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance Company (BHSI) today announced that it has further expanded its leadership team in Dubai with the appointment of executives to fill . . .

